• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小鼠体内吡哆胺的吸收与代谢。II. 肠道组织中吡哆胺向吡哆醛的转化

Absorption and metabolism of pyridoxamine in mice. II. Transformation of pyridoxamine to pyridoxal in intestinal tissues.

作者信息

Sakurai T, Asakura T, Mizuno A, Matsuda M

机构信息

Department of Biochemistry, Jikei University School of Medicine, Tokyo, Japan.

出版信息

J Nutr Sci Vitaminol (Tokyo). 1992 Jun;38(3):227-33. doi: 10.3177/jnsv.38.227.

DOI:10.3177/jnsv.38.227
PMID:1453233
Abstract

The absorption of pyridoxamine from the intestine of the mouse was studied in whole animals. [3H]Pyridoxamine was orally administered and the distribution of isotope between the six recognized forms of vitamin B6 was determined in portal blood after the administration. When small doses (1.4 or 14 nmol) were administered, labeled pyridoxamine could hardly be found in the portal blood, although labeled pyridoxal and pyridoxal phosphate were found in the same blood. However, when a large amount (46 or 140 nmol) was given, a significant amount of labeled pyridoxamine was found with labeled pyridoxal and pyridoxal phosphate in the portal blood. These results suggest that a physiological dose of pyridoxamine is rapidly transformed to pyridoxal in the intestinal tissues and then released in the form of pyridoxal into the portal blood.

摘要

在完整动物中研究了小鼠肠道对吡哆胺的吸收。口服给予[³H]吡哆胺,并在给药后测定门静脉血中维生素B6六种公认形式之间的同位素分布。当给予小剂量(1.4或14 nmol)时,门静脉血中几乎找不到标记的吡哆胺,尽管在同一血液中发现了标记的吡哆醛和磷酸吡哆醛。然而,当给予大量(46或140 nmol)时,门静脉血中发现大量标记的吡哆胺与标记的吡哆醛和磷酸吡哆醛在一起。这些结果表明,生理剂量的吡哆胺在肠道组织中迅速转化为吡哆醛,然后以吡哆醛的形式释放到门静脉血中。

相似文献

1
Absorption and metabolism of pyridoxamine in mice. II. Transformation of pyridoxamine to pyridoxal in intestinal tissues.小鼠体内吡哆胺的吸收与代谢。II. 肠道组织中吡哆胺向吡哆醛的转化
J Nutr Sci Vitaminol (Tokyo). 1992 Jun;38(3):227-33. doi: 10.3177/jnsv.38.227.
2
Absorption and metabolism of pyridoxamine in mice. I. Pyridoxal as the only form of transport in blood.小鼠体内吡哆胺的吸收与代谢。I. 吡哆醛作为血液中唯一的运输形式。
J Nutr Sci Vitaminol (Tokyo). 1991 Aug;37(4):341-8. doi: 10.3177/jnsv.37.341.
3
Transport and metabolism of pyridoxine in the intestine of the mouse.
J Nutr Sci Vitaminol (Tokyo). 1988 Apr;34(2):179-87. doi: 10.3177/jnsv.34.179.
4
Plasma content of B6 vitamers and its relationship to hepatic vitamin B6 metabolism.血浆中维生素B6各形式的含量及其与肝脏维生素B6代谢的关系。
J Clin Invest. 1980 Oct;66(4):688-95. doi: 10.1172/JCI109906.
5
Transport and metabolism of pyridoxine and pyridoxal in mice.
J Nutr Sci Vitaminol (Tokyo). 1987 Feb;33(1):11-9. doi: 10.3177/jnsv.33.11.
6
Intestinal absorption of vitamin B6. I. Pyridoxol uptake by rat intestinal tissue.维生素B6的肠道吸收。I. 大鼠肠道组织对吡哆醇的摄取
J Nutr Sci Vitaminol (Tokyo). 1973 Oct;19(5):401-17. doi: 10.3177/jnsv.19.401.
7
Transport and metabolism of pyridoxamine and pyridoxamine phosphate in the small intestine of the rat.大鼠小肠中吡哆胺及磷酸吡哆胺的转运与代谢
J Nutr. 1979 Sep;109(9):1552-9. doi: 10.1093/jn/109.9.1552.
8
The metabolism of 3H-pyridoxine in rat liver and brain.3H-吡哆醇在大鼠肝脏和大脑中的代谢
Am J Clin Nutr. 1981 Jul;34(7):1321-7. doi: 10.1093/ajcn/34.7.1321.
9
Vitamin B6 metabolism in human red cells: limitations in cofactor activities of pyridoxal and pyridoxal 5-phosphate.
Enzyme. 1982;28(4):242-50. doi: 10.1159/000459108.
10
Separation and quantification of the B6 vitamers in plasma and 4-pyridoxic acid in urine of adolescent girls by reversed-phase high-performance liquid chromatography.采用反相高效液相色谱法分离和定量青春期女孩血浆中的维生素B6各成分及尿液中的4-吡哆酸。
J Chromatogr. 1991 Feb 15;563(2):369-78. doi: 10.1016/0378-4347(91)80044-d.

引用本文的文献

1
Repurposing pyridoxamine for therapeutic intervention of intravascular cell-cell interactions in mouse models of sickle cell disease.重新利用吡哆醛治疗镰状细胞病小鼠模型中的血管内细胞-细胞相互作用。
Haematologica. 2020 Oct 1;105(10):2407-2419. doi: 10.3324/haematol.2019.226720.
2
Advanced Glycation Endproducts Are Increased in the Animal Model of Multiple Sclerosis but Cannot Be Reduced by Pyridoxamine Treatment or Glyoxalase 1 Overexpression.晚期糖基化终产物在多发性硬化症的动物模型中增加,但不能通过吡哆胺治疗或甘油醛 3-磷酸脱氢酶 1 过表达减少。
Int J Mol Sci. 2018 Apr 27;19(5):1311. doi: 10.3390/ijms19051311.
3
Purification and properties of pyridoxal kinase from bovine brain.
牛脑吡哆醛激酶的纯化及性质
Mol Cell Biochem. 1993 Feb 17;119(1-2):203-7. doi: 10.1007/BF00926872.